Crossmark

6-(4-Amino-2-butyl-imidazoquinolyl)-norleucine: Toll-like receptor 7 and 8 agonist amino acid for self-adjuvanting peptide vaccine

Published Online: 2016-02-13

Published Print: 2016-05

Authors

Fujita, Yoshio

Hirai, Kazuyuki

Nishida, Keigo

Taguchi, Hiroaki
Funding

Funding for this research was provided by:

Grants-in-Aid for Young Scientists (B) from Japan Society for the Promotion of Science (26860081)
License Information

Text and Data Mining valid from 2016-02-13

Version of Record valid from 2016-02-13
More Information

Article History

Received: 24 November 2015

Accepted: 28 January 2016

First Online: 13 February 2016

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

: The experimental protocol for this study was approved by the animal care regulations of Suzuka University of Medical Science.

Document is current